197 related articles for article (PubMed ID: 15287377)
21. Escherichia coli bacteraemia in Canberra: incidence and clinical features.
Kennedy KJ; Roberts JL; Collignon PJ
Med J Aust; 2008 Feb; 188(4):209-13. PubMed ID: 18279126
[TBL] [Abstract][Full Text] [Related]
22. Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study.
Aiken AM; Mturi N; Njuguna P; Mohammed S; Berkley JA; Mwangi I; Mwarumba S; Kitsao BS; Lowe BS; Morpeth SC; Hall AJ; Khandawalla I; Scott JAG;
Lancet; 2011 Dec; 378(9808):2021-2027. PubMed ID: 22133536
[TBL] [Abstract][Full Text] [Related]
23. [Bacteremia by Aeromonas spp. in adult patients who go to a university hospital. Analysis of ten episodes].
Soliani MI; Ocaña Carrizo AV; Gasparotto AM; Rocchi M; Monterisi A; Trucchia R; Cometto A; Arce Romero S; Navarro M
Rev Fac Cien Med Univ Nac Cordoba; 2019 Aug; 76(3):154-158. PubMed ID: 31465182
[TBL] [Abstract][Full Text] [Related]
24. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa bacteraemia in an academic hospital in South Africa.
Perovic O; Koornhof HJ; Crewe-Brown HH; Duse AG; van Nierop W; Galpin JS
S Afr Med J; 2008 Aug; 98(8):626-32. PubMed ID: 18928043
[TBL] [Abstract][Full Text] [Related]
26. Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre.
Aoun M; Van der Auwera P; Devleeshouwer C; Daneau D; Seraj N; Meunier F; Gerain J
J Hosp Infect; 1992 Dec; 22(4):307-16. PubMed ID: 1363110
[TBL] [Abstract][Full Text] [Related]
27. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes.
Ho PL; Chan WM; Tsang KW; Wong SS; Young K
Scand J Infect Dis; 2002; 34(8):567-73. PubMed ID: 12238570
[TBL] [Abstract][Full Text] [Related]
28. Polymicrobial pneumococcal bacteraemia: a case-control study.
Grau I; Ardanuy C; Schulze MH; Liñares J; Pallares R
Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):911-915. PubMed ID: 28054228
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
[TBL] [Abstract][Full Text] [Related]
30. Are corticosteroids or end-stage renal failure associated with an afebrile presentation of Gram-negative bacteraemia?
Even Dar R; Kurnik D; Bishop B; Bogner I; Azzam Z; Paul M; Neuberger A
Int J Antimicrob Agents; 2020 Sep; 56(3):106070. PubMed ID: 32610183
[TBL] [Abstract][Full Text] [Related]
31. An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait.
Jamal WY; El-Din K; Rotimi VO; Chugh TD
J Hosp Infect; 1999 Sep; 43(1):49-56. PubMed ID: 10462639
[TBL] [Abstract][Full Text] [Related]
32. Aeromonas bacteremia: review of 59 episodes.
Ko WC; Chuang YC
Clin Infect Dis; 1995 May; 20(5):1298-304. PubMed ID: 7620014
[TBL] [Abstract][Full Text] [Related]
33. Gram-negative bacteremia in non-neutropenic patients: a 3-year review.
Gikas A; Samonis G; Christidou A; Papadakis J; Kofteridis D; Tselentis Y; Tsaparas N
Infection; 1998; 26(3):155-9. PubMed ID: 9646106
[TBL] [Abstract][Full Text] [Related]
34. Bacteraemia in a community and a university hospital.
Elhanan G; Raz R; Pitlik SD; Sharir R; Konisberger H; Samra Z; Kennes Y; Drucker M; Leibovici L
J Antimicrob Chemother; 1995 Oct; 36(4):681-95. PubMed ID: 8591943
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
[TBL] [Abstract][Full Text] [Related]
36. Five-year prospective study of bacteraemic urinary tract infection in a single institution.
Bishara J; Leibovici L; Huminer D; Drucker M; Samra Z; Konisberger H; Pitlik S
Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):563-7. PubMed ID: 9323466
[TBL] [Abstract][Full Text] [Related]
37. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals.
Nagao M
Clin Microbiol Infect; 2013 Sep; 19(9):852-8. PubMed ID: 23176224
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological study of secondary bloodstream infections: The forgotten issue.
Sante L; Aguirre-Jaime A; Miguel MA; Ramos MJ; Pedroso Y; Lecuona M
J Infect Public Health; 2019; 12(1):37-42. PubMed ID: 30266540
[TBL] [Abstract][Full Text] [Related]
39. External validation of bloodstream infection mortality risk score in a population-based cohort.
Al-Hasan MN; Juhn YJ; Bang DW; Yang HJ; Baddour LM
Clin Microbiol Infect; 2014 Sep; 20(9):886-91. PubMed ID: 25455590
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.
Mascitti H; Duran C; Nemo EM; Bouchand F; Câlin R; Descatha A; Gaillard JL; Lawrence C; Davido B; Barbier F; Dinh A
Antimicrob Resist Infect Control; 2018; 7():116. PubMed ID: 30288256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
